Skip to content

Pfizer PFE Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin293.4%+23.2pp292.1%+36.2pp289.7%+47.6pp284.1%+48.3pp270.1%+22.6pp
Efficiency
Asset turnover1.2×+0.1×1.2×+0.1×1.2×+0.1×1.2×0.0×1.1×-0.2×
Liquidity
Current ratio4.8×+0.6×4.9×+0.8×4.9×+1.1×4.6×-0.6×4.3×-2.2×
Leverage
Debt-to-equity2.9×+0.1×2.8×+0.1×2.8×0.0×2.8×0.0×2.8×0.0×
Per Share
Book value per share$62.64-0.4%$62.74-0.8%$63.08-0.4%$63.02-2.1%$62.87-5.2%
Valuation
Market capitalization$584.38B-5.2%$568.37B-9.7%$577.14B-10.1%$596.25B-10.4%$616.32B-13.7%
Price / sales9.3×-0.9×-1.7×9.1×-1.9×9.5×-1.5×10.2×-0.6×
Price / book6.5×-0.3×6.3×-0.6×6.4×-0.7×6.6×-0.6×6.9×-0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Pfizer's ratios come from?
Every ratio is computed from Pfizer's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.